<?xml version="1.0" encoding="UTF-8" standalone="yes"?><EventTranscript id="5378822"><Name>Full Year 2014 Otsuka Holdings Co Ltd Earnings Presentation Webcast</Name><Company>Otsuka Holdings Co Ltd</Company><Drugs><Drug>aripiprazole</Drug><Drug>dasatinib</Drug><Drug>TA-102</Drug><Drug>rebamipide (oral, gastritis), Otsuka Pharmaceuticals</Drug><Drug>sertraline</Drug><Drug>AT-7519</Drug><Drug>carteolol hydrochloride (ophthalmic, ocular hypertension), Otsuka/Senju/Polifarma</Drug><Drug>brexpiprazole</Drug><Drug>cilostazol</Drug><Drug>bilastine</Drug><Drug>vonoprazan fumarate (oral, GERD/peptic ulcer), Takeda</Drug><Drug>carteolol + latanoprost (eye drop formulation, glaucoma), Otsuka</Drug><Drug>aripiprazole (intramuscular depot, schizophrenia), Otsuka/H Lundbeck</Drug><Drug>tipiracil hydrochloride (cancer), Taiho</Drug><Drug>OPB-111001</Drug><Drug>latanoprost</Drug><Drug>onalespib</Drug><Drug>piperacillin + tazobactam (injectable), Wyeth/Toyama/Taiho</Drug><Drug>paclitaxel (albumin-bound nanoparticle, intravenous), Celgene</Drug><Drug>guadecitabine sodium</Drug><Drug>levetiracetam (oral), UCB</Drug><Drug>tolvaptan</Drug><Drug>tegafur + gimeracil + oteracil potassium + calcium folinate (oral, solid tumors/pancreatic cancer), Taiho</Drug><Drug>delamanid</Drug></Drugs></EventTranscript>